As of December 2024, Sonoma Pharmaceuticals has a market cap of $35.43M. This makes Sonoma Pharmaceuticals the world's 4518th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.05M | -16.67% |
2023 | $2.46M | -83.93% |
2022 | $15.32M | -75.44% |
2021 | $62.38M | -37.19% |
2020 | $99.31M | 66.51% |
2019 | $59.64M | -31.77% |
2018 | $87.41M | -86.97% |
2017 | $670.97M | 8.13% |
2016 | $620.49M | -12.35% |
2015 | $707.90M | -19.58% |
2014 | $880.26M | -58.91% |
2013 | $2.14B | -18.50% |
2012 | $2.63B | -41.90% |
2011 | $4.52B | -37.87% |
2010 | $7.28B | -7.65% |
2009 | $7.89B | 27.97% |
2008 | $6.16B | -65.12% |
2007 | $17.67B | - |